home

Health Tip: Craving Something Crunchy?

Healthdrugs2016-03-29 10:21 Read   136

When you can't stop thinking about a crunchy, salty snack, give your body a healthier version of what you crave.

Dr. Reddy’s Laboratories and XenoPort Enter into a U.S. Licensing Agreement for XP23829

FrontierBusinesswire2016-03-29 10:10 Read   113

Dr. Reddy's Laboratories and XenoPort, announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral new chemical entity, XP23829.

Aduro Biotech helps launch new immunotherapy, vaccine effort

FrontierUC BERKELEY2016-03-29 09:58 Read   127

UC Berkeley cancer immunologists are teaming up with colleagues working on infectious disease to create a new Immunotherapeutics and Vaccine Research Initiative, fueled by $7.5 million in funding from Aduro Biotech, Inc., a Berkeley company that develops immunotherapies for cancer and other diseases.

Lundbeck and Takeda receive Complete Response Letter by the FDA for Brintellix® (vortioxetine) sNDA

RegulatorGlobenewswire2016-03-29 09:41 Read   455

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the supplemental new drug application (sNDA) to include new data in the clinical trials section of the U.S. label of Brintellix® (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with major depressive disorder (MDD).

Alder Reports Phase 2b Trial of ALD403 Meets Primary and Secondary Endpoints Demonstrating Migraine Prevention in Patients with Chronic Migraine

Trendyahoo2016-03-29 09:34 Read   175

Alder BioPharmaceuticals, Inc. (ALDR), today announced positive top-line data from two clinical trials evaluating ALD403, Alder’s proprietary monoclonal antibody product candidate for migraine prevention that targets calcitonin gene-related peptide (CGRP).

Apricus Reports Top-Line Phase 2b Data for Fispemifene in Symptomatic Secondary Hypogonadism

TrendYAHOO2016-03-29 09:16 Read   109

Fispemifene Failed to Achieve Statistical Significance in Key Clinical Benefit Endpoints Despite Increase in Testosterone Levels

FDA Does Not Grant Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection)

CommentsBusinesswire2016-03-29 09:01 Read   148

We are disappointed with the agency’s decision regarding orphan drug exclusivity for BENDEKA, which we believe to be incorrect

South Korea says finds ducks infected with bird flu

EVENTSreuters2016-03-28 12:23 Read   99

South Korea has detected bird flu in ducks on a poultry farm near Seoul, an agriculture ministry official told Reuters on Monday, the first discovery in four months and a month after the country regained its bird flu-free status.

Leishmaniasis treatment Impavido available in the US

CommentsHEALIO2016-03-28 11:11 Read   621

Impavido, the only FDA-approved oral treatment for visceral, mucosal and cutaneous leishmaniasis, is now available in the United States, according to press release.

West Coast Bio Roundup: Gilead, Affymetrix, Acutus, Frazier & More

R&DXconomy2016-03-28 10:38 Read   93

Gilead Sciences is back at the top of our chart for the second week in a row. After halting trials last week in the United States and Europe over its cancer drug idelalisib, a federal jury in San Jose, CA, upheld the validity of two Merck patents this week in a case that could force Gilead to turn over billions.

Chinese authorities arrest more than 130 people in relation to vaccine scandal

EVENTSFirstword2016-03-28 10:25 Read   173

Officials in China have opened 69 cases against more than 130 people in relation to the sale of illegal vaccines across the country.

Strong patent regime the only way to boost drug innovation

FrontierFirstword2016-03-28 10:20 Read   177

Sanjiv Navangul, managing director of Janssen India, said the company will not sell tuberculosis drug bedaquiline, which was recently launched in the country, in the private market, Business Line reported.